B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs include rituximab.
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs include rituximab, ibritumab tiuxetan, ofatumumab, obinutuzumab and tositumomab. 3D rendering based on protein data bank entry 1s8b. Cartoon representation with secondary structure coloring (green sheets, red helices).
Size: 8000px × 6894px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: -cell, -lymphocyte, 20, 3d, acid, amino, antibody, antigen, arthritis, atoms, cd, cd20, cluster, differentiation, disease, health, histology, ibritumab, illustration, immunohistochemistry, leukemia, lupus, lymphocyte, lymphoma, model, molecular, molecule, ms4a1, multiple, obinutuzumab, pdb_1s8b, peptide, polymer, polypeptide, protein, rendering, rheumatoid, rituximab, science, scientific, sclerosis, structure, surface, tiuxetan, veltuzumab
